IVERS-READ GILLIAN C
Insider CIK 1268304 · BPTH Director · CLVS See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CLVS Clovis Oncology, Inc. | S Sale | 2022-11-02 | 2022-11-03 | 1,675 | $0.98 | $1.6K | 290,993 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2022-11-02 | 2022-11-03 | 2,006 | $0.98 | $2.0K | 293,612 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-11-01 | 2022-11-03 | 4,625 | — | $0 | 23,125 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-11-01 | 2022-11-03 | 3,749 | — | $0 | 3,750 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-11-01 | 2022-11-03 | 3,749 | — | $0 | 292,668 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-11-01 | 2022-11-03 | 4,625 | — | $0 | 295,618 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2022-09-02 | 2022-09-06 | 2,234 | $1.20 | $2.7K | 288,919 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-09-01 | 2022-09-06 | 5,063 | — | $0 | 50,625 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-09-01 | 2022-09-06 | 5,063 | — | $0 | 291,153 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2022-08-02 | 2022-08-03 | 1,702 | $1.46 | $2.5K | 283,565 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2022-08-02 | 2022-08-03 | 2,100 | $1.46 | $3.1K | 286,090 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-08-01 | 2022-08-03 | 3,749 | — | $0 | 7,499 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-08-01 | 2022-08-03 | 4,625 | — | $0 | 27,750 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-08-01 | 2022-08-03 | 4,625 | — | $0 | 288,190 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-08-01 | 2022-08-03 | 3,749 | — | $0 | 285,267 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2022-06-02 | 2022-06-03 | 2,327 | $0.64 | $1.5K | 281,518 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-06-01 | 2022-06-03 | 5,062 | — | $0 | 55,688 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-06-01 | 2022-06-03 | 5,062 | — | $0 | 283,845 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2022-05-02 | 2022-05-03 | 2,062 | $1.97 | $4.1K | 278,783 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2022-05-02 | 2022-05-03 | 1,671 | $1.97 | $3.3K | 276,220 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-05-01 | 2022-05-03 | 4,625 | — | $0 | 32,375 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-05-01 | 2022-05-03 | 3,749 | — | $0 | 11,248 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-05-01 | 2022-05-03 | 4,625 | — | $0 | 280,845 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-05-01 | 2022-05-03 | 3,749 | — | $0 | 277,891 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2022-03-02 | 2022-03-03 | 10,416 | $1.87 | $19.5K | 274,142 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2022-03-02 | 2022-03-03 | 354 | $1.87 | $662 | 264,308 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-03-01 | 2022-03-03 | 688 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2022-03-01 | 2022-03-03 | 81,000 | — | $0 | 81,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-03-01 | 2022-03-03 | 20,250 | — | $0 | 60,750 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-03-01 | 2022-03-03 | 688 | — | $0 | 264,662 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-03-01 | 2022-03-03 | 20,250 | — | $0 | 284,558 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2022-02-02 | 2022-02-03 | 1,989 | $1.94 | $3.9K | 261,802 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2022-02-02 | 2022-02-03 | 2,453 | $1.94 | $4.8K | 263,974 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-02-01 | 2022-02-03 | 4,625 | — | $0 | 37,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-02-01 | 2022-02-03 | 3,750 | — | $0 | 14,997 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-02-01 | 2022-02-03 | 3,750 | — | $0 | 263,791 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-02-01 | 2022-02-03 | 4,625 | — | $0 | 266,427 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-12-02 | 2021-12-03 | 304 | $3.00 | $912 | 260,041 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-12-01 | 2021-12-03 | 687 | — | $0 | 688 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-12-01 | 2021-12-03 | 687 | — | $0 | 260,345 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-11-02 | 2021-11-03 | 1,655 | $4.55 | $7.5K | 257,074 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-11-02 | 2021-11-03 | 2,041 | $4.55 | $9.3K | 259,658 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-11-01 | 2021-11-03 | 4,625 | — | $0 | 41,625 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-11-01 | 2021-11-03 | 3,749 | — | $0 | 18,747 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-11-01 | 2021-11-03 | 4,625 | — | $0 | 261,699 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-11-01 | 2021-11-03 | 3,749 | — | $0 | 258,729 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-09-02 | 2021-09-03 | 304 | $4.89 | $1.5K | 254,980 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-09-01 | 2021-09-03 | 688 | — | $0 | 1,375 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-09-01 | 2021-09-03 | 688 | — | $0 | 255,284 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-08-03 | 2021-08-03 | 2,034 | $4.82 | $9.8K | 254,596 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-08-03 | 2021-08-03 | 1,649 | $4.82 | $7.9K | 252,005 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-08-01 | 2021-08-03 | 3,749 | — | $0 | 22,496 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-08-01 | 2021-08-03 | 4,625 | — | $0 | 46,150 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-08-01 | 2021-08-03 | 4,625 | — | $0 | 256,630 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-08-01 | 2021-08-03 | 3,749 | — | $0 | 253,654 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-06-03 | 2021-06-03 | 283 | $5.63 | $1.6K | 249,905 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-06-01 | 2021-06-03 | 687 | — | $0 | 2,063 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-06-01 | 2021-06-03 | 687 | — | $0 | 250,188 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-05-04 | 2021-05-04 | 1,769 | $5.54 | $9.8K | 247,059 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-05-04 | 2021-05-04 | 2,183 | $5.54 | $12.1K | 249,501 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-05-01 | 2021-05-04 | 3,749 | — | $0 | 26,245 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-05-01 | 2021-05-04 | 4,625 | — | $0 | 50,875 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-05-01 | 2021-05-04 | 4,625 | — | $0 | 251,684 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-05-01 | 2021-05-04 | 3,749 | — | $0 | 248,828 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-03-02 | 2021-03-03 | 276 | $6.29 | $1.7K | 244,695 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-03-02 | 2021-03-03 | 304 | $6.29 | $1.9K | 245,079 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-03-01 | 2021-03-03 | 688 | — | $0 | 2,750 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-03-01 | 2021-03-03 | 625 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2021-03-01 | 2021-03-03 | 81,000 | — | $0 | 81,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-03-01 | 2021-03-03 | 625 | — | $0 | 244,971 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-03-01 | 2021-03-03 | 688 | — | $0 | 245,383 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-02-02 | 2021-02-03 | 1,959 | $7.97 | $15.6K | 234,877 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-02-02 | 2021-02-03 | 9,031 | $7.97 | $72.0K | 244,346 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-02-01 | 2021-02-03 | 18,500 | — | $0 | 55,500 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-02-01 | 2021-02-03 | 3,750 | — | $0 | 29,994 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-02-01 | 2021-02-03 | 18,500 | — | $0 | 253,377 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-02-01 | 2021-02-03 | 3,750 | — | $0 | 236,836 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-12-21 | 2020-12-23 | 1,875 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-12-21 | 2020-12-23 | 829 | $5.68 | $4.7K | 233,086 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-12-21 | 2020-12-23 | 1,875 | — | $0 | 233,915 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-12-10 | 2020-12-14 | 68,965 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2020-12-10 | 2020-12-14 | 52,447 | $4.81 | $252.3K | 232,040 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-12-10 | 2020-12-14 | 68,965 | $3.28 | $226.2K | 284,487 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-12-03 | 2020-12-07 | 625 | — | $0 | 625 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-12-03 | 2020-12-07 | 687 | — | $0 | 3,438 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-12-03 | 2020-12-07 | 625 | — | $0 | 215,416 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-12-03 | 2020-12-07 | 687 | — | $0 | 215,826 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-12-03 | 2020-12-07 | 304 | $4.89 | $1.5K | 215,522 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-12-03 | 2020-12-07 | 277 | $4.89 | $1.4K | 215,139 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-11-03 | 2020-11-05 | 3,749 | — | $0 | 33,744 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-11-03 | 2020-11-05 | 1,689 | $4.93 | $8.3K | 214,791 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-11-03 | 2020-11-05 | 3,749 | — | $0 | 216,480 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-09-21 | 2020-09-23 | 1,875 | — | $0 | 1,875 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-09-21 | 2020-09-23 | 1,875 | — | $0 | 213,569 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-09-21 | 2020-09-23 | 9 | $6.86 | $62 | 213,560 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-09-21 | 2020-09-23 | 829 | $6.85 | $5.7K | 212,731 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-09-03 | 2020-09-08 | 625 | — | $0 | 1,250 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-09-03 | 2020-09-08 | 688 | — | $0 | 4,125 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-09-03 | 2020-09-08 | 263 | $5.30 | $1.4K | 211,296 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-09-03 | 2020-09-08 | 625 | — | $0 | 211,559 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-09-03 | 2020-09-08 | 688 | — | $0 | 211,984 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-09-03 | 2020-09-08 | 290 | $5.30 | $1.5K | 211,694 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-08-03 | 2020-08-05 | 3,749 | — | $0 | 37,493 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-08-03 | 2020-08-05 | 1,670 | $5.92 | $9.9K | 210,934 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-08-03 | 2020-08-05 | 3,749 | — | $0 | 212,604 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-06-22 | 2020-06-23 | 1,875 | — | $0 | 3,750 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-06-22 | 2020-06-23 | 829 | $6.74 | $5.6K | 208,855 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-06-22 | 2020-06-23 | 1,875 | — | $0 | 209,684 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-06-03 | 2020-06-05 | 625 | — | $0 | 1,875 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-06-03 | 2020-06-05 | 687 | — | $0 | 4,813 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-06-03 | 2020-06-05 | 625 | — | $0 | 207,720 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-06-03 | 2020-06-05 | 285 | $7.03 | $2.0K | 207,435 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-06-03 | 2020-06-05 | 313 | $7.03 | $2.2K | 207,809 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-06-03 | 2020-06-05 | 687 | — | $0 | 208,122 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-05-05 | 2020-05-07 | 3,749 | — | $0 | 41,242 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-05-05 | 2020-05-07 | 1,475 | $8.10 | $11.9K | 207,095 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-05-05 | 2020-05-07 | 3,749 | — | $0 | 208,570 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-03-20 | 2020-03-23 | 1,875 | — | $0 | 5,625 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-03-20 | 2020-03-23 | 829 | $4.60 | $3.8K | 204,821 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-03-20 | 2020-03-23 | 1,875 | — | $0 | 205,650 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-03-03 | 2020-03-05 | 625 | — | $0 | 2,500 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-03-03 | 2020-03-05 | 688 | — | $0 | 5,500 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-03-03 | 2020-03-05 | 288 | $7.20 | $2.1K | 203,404 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-03-03 | 2020-03-05 | 625 | — | $0 | 203,692 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-03-03 | 2020-03-05 | 317 | $7.20 | $2.3K | 203,775 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-03-03 | 2020-03-05 | 688 | — | $0 | 204,092 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-02-04 | 2020-02-06 | 14,997 | — | $0 | 44,991 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-02-04 | 2020-02-06 | 14,997 | — | $0 | 210,271 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-02-04 | 2020-02-06 | 7,204 | $8.41 | $60.6K | 203,067 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2020-01-31 | 2020-01-31 | 74,000 | — | $0 | 74,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-12-20 | 2019-12-26 | 1,875 | — | $0 | 7,500 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-12-20 | 2019-12-26 | 830 | $11.30 | $9.4K | 195,274 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-12-20 | 2019-12-26 | 1,875 | — | $0 | 196,104 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-12-03 | 2019-12-05 | 687 | — | $0 | 6,188 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-12-03 | 2019-12-05 | 625 | — | $0 | 3,125 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-12-03 | 2019-12-05 | 625 | — | $0 | 194,134 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-12-03 | 2019-12-05 | 687 | — | $0 | 194,539 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-12-03 | 2019-12-05 | 310 | $14.59 | $4.5K | 194,229 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-12-03 | 2019-12-05 | 282 | $14.60 | $4.1K | 193,852 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-09-20 | 2019-09-24 | 1,875 | — | $0 | 9,375 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-09-20 | 2019-09-24 | 1,875 | — | $0 | 194,346 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-09-20 | 2019-09-24 | 837 | $4.80 | $4.0K | 193,509 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-09-04 | 2019-09-06 | 625 | — | $0 | 3,750 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-09-04 | 2019-09-06 | 688 | — | $0 | 6,875 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-09-04 | 2019-09-06 | 330 | $5.21 | $1.7K | 192,471 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-09-04 | 2019-09-06 | 625 | — | $0 | 192,413 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-09-04 | 2019-09-06 | 300 | $5.21 | $1.6K | 192,113 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-09-04 | 2019-09-06 | 688 | — | $0 | 192,801 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-06-20 | 2019-06-24 | 1,875 | — | $0 | 11,250 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-06-20 | 2019-06-24 | 1,875 | — | $0 | 192,617 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-06-20 | 2019-06-24 | 829 | $14.70 | $12.2K | 191,788 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-06-04 | 2019-06-06 | 625 | — | $0 | 4,375 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-06-04 | 2019-06-06 | 687 | — | $0 | 7,563 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-06-04 | 2019-06-06 | 302 | $15.07 | $4.6K | 190,742 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-06-04 | 2019-06-06 | 625 | — | $0 | 190,632 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-06-04 | 2019-06-06 | 275 | $15.07 | $4.1K | 190,357 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-06-04 | 2019-06-06 | 687 | — | $0 | 191,044 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-03-20 | 2019-03-21 | 1,875 | — | $0 | 13,125 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-03-20 | 2019-03-21 | 1,875 | — | $0 | 190,837 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-03-20 | 2019-03-21 | 830 | $26.13 | $21.7K | 190,007 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-03-05 | 2019-03-06 | 2,750 | — | $0 | 8,250 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-03-05 | 2019-03-06 | 625 | — | $0 | 5,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-03-05 | 2019-03-06 | 1,295 | $29.29 | $37.9K | 188,962 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-03-05 | 2019-03-06 | 625 | — | $0 | 187,823 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-03-05 | 2019-03-06 | 316 | $29.29 | $9.3K | 187,507 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-03-05 | 2019-03-06 | 2,750 | — | $0 | 190,257 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2019-02-01 | 2019-02-04 | 19,996 | — | $0 | 19,996 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2019-02-01 | 2019-02-04 | 59,988 | — | $0 | 59,988 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2018-12-20 | 2018-12-26 | 1,875 | — | $0 | 15,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2018-12-20 | 2018-12-26 | 1,875 | — | $0 | 188,027 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2018-12-20 | 2018-12-26 | 829 | $17.72 | $14.7K | 187,198 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2018-12-04 | 2018-12-06 | 625 | — | $0 | 5,625 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2018-12-04 | 2018-12-06 | 250 | $21.23 | $5.3K | 186,152 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2018-12-04 | 2018-12-06 | 625 | — | $0 | 186,402 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2018-09-20 | 2018-09-24 | 1,875 | — | $0 | 16,875 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2018-09-20 | 2018-09-24 | 829 | $32.21 | $26.7K | 185,777 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2018-09-20 | 2018-09-24 | 1,875 | — | $0 | 186,606 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2018-09-05 | 2018-09-07 | 625 | — | $0 | 6,250 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2018-09-05 | 2018-09-07 | 625 | — | $0 | 185,013 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2018-09-05 | 2018-09-07 | 282 | $35.75 | $10.1K | 184,731 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2018-06-20 | 2018-06-21 | 1,875 | — | $0 | 18,750 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2018-06-20 | 2018-06-21 | 829 | $45.75 | $37.9K | 184,388 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2018-06-20 | 2018-06-21 | 1,875 | — | $0 | 185,217 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2018-06-06 | 2018-06-08 | 625 | — | $0 | 6,875 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2018-06-06 | 2018-06-08 | 278 | $47.70 | $13.3K | 183,342 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2018-06-06 | 2018-06-08 | 625 | — | $0 | 183,620 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2018-03-20 | 2018-03-21 | 1,875 | — | $0 | 20,625 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2018-03-20 | 2018-03-21 | 1,875 | — | $0 | 183,824 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2018-03-20 | 2018-03-21 | 829 | $56.75 | $47.0K | 182,995 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2018-03-06 | 2018-03-07 | 2,500 | — | $0 | 7,500 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2018-03-06 | 2018-03-07 | 1,122 | $58.43 | $65.6K | 181,949 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2018-03-06 | 2018-03-07 | 2,500 | — | $0 | 183,071 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2018-03-01 | 2018-03-02 | 11,000 | — | $0 | 11,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2018-03-01 | 2018-03-02 | 11,000 | — | $0 | 11,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2018-02-15 | 2018-02-16 | 3,000 | $54.09 | $162.3K | 180,571 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2018-01-16 | 2018-01-17 | 3,000 | $59.16 | $177.5K | 183,571 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2017-12-20 | 2017-12-21 | 7,500 | — | $0 | 22,500 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2017-12-20 | 2017-12-21 | 7,500 | — | $0 | 190,083 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2017-12-20 | 2017-12-21 | 3,512 | $63.80 | $224.1K | 186,571 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2017-12-15 | 2017-12-18 | 3,000 | $64.16 | $192.5K | 182,583 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2017-11-15 | 2017-11-16 | 3,000 | $63.70 | $191.1K | 185,583 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2017-10-16 | 2017-10-17 | 3,000 | $84.54 | $253.6K | 188,583 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2017-09-15 | 2017-09-18 | 3,000 | $69.50 | $208.5K | 191,583 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2017-08-15 | 2017-08-15 | 3,000 | $70.05 | $210.2K | 194,583 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2017-07-17 | 2017-07-17 | 3,000 | $91.56 | $274.7K | 197,583 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2017-06-15 | 2017-06-15 | 3,000 | $61.82 | $185.5K | 200,583 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2017-05-15 | 2017-05-15 | 3,000 | $47.39 | $142.2K | 203,583 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2017-04-17 | 2017-04-17 | 3,000 | $56.02 | $168.1K | 206,583 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2017-03-27 | 2017-03-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2017-03-27 | 2017-03-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2017-03-15 | 2017-03-15 | 3,000 | $66.99 | $201.0K | 209,583 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2016-12-19 | 2016-12-19 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other deriv | 2016-09-16 | 2016-09-19 | 8,750 | — | $0 | 26,250 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-10-15 | 2015-10-16 | 3,000 | $91.91 | $275.7K | 212,583 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-09-18 | 2015-09-22 | 3,000 | $112.56 | $337.7K | 215,583 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2015-03-02 | 2015-03-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| BPTH BIO-PATH HOLDINGS INC | A Award deriv | 2014-04-25 | 2014-04-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2014-01-10 | 2014-01-14 | 70,000 | — | $0 | 70,000 | SEC↗ |
| BPTH BIO-PATH HOLDINGS INC | A Award deriv | 2013-04-25 | 2013-04-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2013-03-01 | 2013-03-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| BPTH BIO-PATH HOLDINGS INC | A Award deriv | 2013-02-19 | 2013-02-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2012-03-01 | 2012-03-05 | 50,000 | — | $0 | 50,000 | SEC↗ |